Supporting the Pharmaceutical Industry with 21 CFR Part 11 Compliance Readiness
White Paper Apr 24, 2018
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
Integration of PANalytical systems in a 21 CFR Part 11 compliant laboratory environment was straightforward because PANalytical offers tools and services to guarantee authenticity, integrity and confidentiality of electronic records and electronic signatures. Also the final system qualification is supported with products and services.
Related White Papers
8 Reasons why it’s Time to Upgrade to Automated ImagingWhite Paper
Why automated image analysis is rapidly replacing manual microscopy for characterizing particle shape and how combining it with Raman spectroscopy adds chemical identification.READ MORE
7 Key Factors When Considering a Benchtop X-ray DiffractometerWhite Paper
In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.READ MORE
Mining AutomationWhite Paper
This paper describes how robots and automation represent the future of mining, by taking many challenges out of the equation. Lower commodity prices, weaker demand, environmental regulations, lower ore grades, higher running costs are some of the main challenges that the mining industry has to deal with every day.READ MORE
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018